¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024³â ´ëÇѽÉÇ÷°ü¾à¹°Ä¡·áÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-08

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024³â ´ëÇѽÉÇ÷°ü¾à¹°Ä¡·áÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-08
±³À°ÀÏÀÚ : 2024-06-08
±³À°Àå¼Ò : ¼¼Á¾´ëÇб³ ´ë¾çAI¼¾ÅÍ AIȦ / ÄÁÆÛ·±½º·ë 1~3

±³À°ÁÖÁ¦ : 2024³â ´ëÇѽÉÇ÷°ü¾à¹°Ä¡·áÇÐȸ Ãá°èÇмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇѽÉÇ÷°ü¾à¹°Ä¡·áÇÐȸ
´ã´çÀÚ : ÃÖÀº¿µ
¿¬¶ôó : 070-8873-6030  

À̸ÞÀÏ : k-iscp@kscvp.org

±³À°Á¾·ù : ³»°ú, ½Å°æ¿Ü°ú

Âü¼®¿¹»óÀÎ : 160¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 50ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 09:00~09:20 Beta blockers/Calcium channel blockers À±¹ÎÀç(¼­¿ïÀÇ´ë ¼øȯ±â³»°ú )

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 09:20~09:40 Diuretics ¾ÈÈ¿¼® (°¡Å縯ÀÇ´ë ¼øȯ±â³»°ú )

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 09:40~10:00 Statin/Fibrate/Omega-3 fatty acid ½Åµ¿È£(¿¬¼¼ÀÇ´ë ½ÉÀå³»°ú)

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 10:00~10:20 Inotropics & Vasopressors ÃÖÁ¤Çö( ºÎ»êÀÇ´ë ¼øȯ±â³»°ú )

Åä·Ð 06¿ù 08ÀÏ AIȦ 10:20~10:30 Åä·Ð ()

ÈÞ½Ä 06¿ù 08ÀÏ 10:30~10:50 ÈÞ½Ä ()

±³À°½Ã°£ 06¿ù 08ÀÏ ÄÁÆÛ·±½º·ë 1~3 10:50~11:10 It's new, but it's not new anymore: RNA-based therapeutics for CVD À§Áø (°¡ÃµÀÇ´ë ½ÉÀå³»°ú)

±³À°½Ã°£ 06¿ù 08ÀÏ ÄÁÆÛ·±½º·ë 1~3 11:10~11:30 Can RNA drugs be the game changers for dyslipidemia treatement ? ¹ÚÀçÇü(°í·ÁÀÇ´ë ¼øȯ±â³»°ú )

±³À°½Ã°£ 06¿ù 08ÀÏ ÄÁÆÛ·±½º·ë 1~3 11:30~11:50 The world's first RNA interference drug: Patisiran in ATTR amyloidosis with cardiomyopathy ±è°æÈñ (ÀÎõ¼¼Á¾º´¿ø ½ÉÀå³»°ú)

±³À°½Ã°£ 06¿ù 08ÀÏ ÄÁÆÛ·±½º·ë 1~3 11:50~12:10 Are there  even new RNA drugs for treating HTN ? Á¤¹ÌÇâ (°¡Å縯ÀÇ´ë ¼øȯ±â³»°ú )

Åä·Ð 06¿ù 08ÀÏ ÄÁÆÛ·±½º·ë 1~3 12:10~12:20 Åä·Ð ()

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 10:50~11:10 Cancer induced thromboembolism È«Á¤¾Ö(ÇѸ²ÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 11:10~11:30 Cancer and Heart Failure ¹ÚÁøÁÖ(¼­¿ïÀÇ´ë ½ÉÀåÇ÷°ü³»°ú )

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 11:30~11:50 Chemotherapy induced Cardiovascular adverse drug reaction È«¼Ò¿¬ (ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¾àÁ¦ºÎ)

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 11:50~12:10 Role of Pharmacist in Cardio-oncoloy À¯Áö¿¬(ÇѸ²´ë¼º½Éº´¿ø ¾àÁ¦ºÎ)

Åä·Ð 06¿ù 08ÀÏ AIȦ 12:10~12:20 Åä·Ð ()

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 12:20~12:40 Integrating Artificial Intelligence into Electrocardiography: A New Era of  Cardiology ¹é¿ë¼ö(ÀÎÇÏÀÇ´ë ½ÉÀå³»°ú)

½Ä»ç 06¿ù 08ÀÏ 12:40~13:30 ½Ä»ç ()

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 13:30~13:50 Overview: Current anti-obesity medication ¼­Àçºó(¼­¿ïÀÇ´ë ½ÉÀå³»°ú)

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 13:50~14:10 Weekly GLP-1 Receptor Agonist (Semaglutide) À̼¼Á¤(Â÷ÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 14:10~14:30 GLP-1/GIP Dual Agonist (Tirzepatide) õ´ë¿µ(ÇѸ²ÀÇ´ë ½ÉÀå³»°ú)

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 14:30~14:50 Upcoming drugs to conquer obesity Á¤Ã¢Èñ(¿ï»êÀÇ´ë ³»ºÐºñ³»°ú)

Åä·Ð 06¿ù 08ÀÏ AIȦ 14:50~15:00 Åä·Ð ()

ÈÞ½Ä 06¿ù 08ÀÏ 15:00~15:20 ÈÞ½Ä ()

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 15:20~15:40 Introduction of arterial stiffness ±èÇзÉ(¼­¿ïÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 15:40~16:00 Statin Á¤ÀçÈÆ(µ¿±¹ÀÇ´ë ¼øȯ±â³»°ú )

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 16:00~16:20 RAS blockers ½ÅÁ¤ÈÆ(ÇѾçÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 16:20~16:40 Emerging drugs (sacubitril/valsartan and SGLT2 inhibitors) °ø¹Î±Ô(¼øõÇâÀÇ´ë ½ÉÀå³»°ú )

Åä·Ð 06¿ù 08ÀÏ AIȦ 16:50~17:00 Åä·Ð ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024³â ´ëÇѽÉÇ÷°ü¾à¹°Ä¡·áÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-08""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °æÈñ´ëÇб³º´¿ø 2024 Kyung Hee Knee Symposium : 2024-06-08
´ÙÀ½±Û (¿Â¶óÀÎ) 2024³â ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ °¨¿°°ü¸®ÀÇ»ç ¿¬¼ö±³À° : 2024-06-08
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 28 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 27 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 31 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 32 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 29 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 20 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 7 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 8 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 16 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 11 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 6 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 20 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 12 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 19 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 13 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷